ArticleScience progress
Association between age-adjusted visceral fat index (AVAI) and congestive heart failure: A cross-sectional study.
Article in Science progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveCongestive heart failure (CHF) is a chronic disease marked by impaired cardiac function, and excess visceral fat has been reported to be associated with CHF. While the age-adjusted visceral adiposity index (AVAI) is a novel metric for evaluating visceral fat, its association with CHF has not been well elucidated.MethodsThe association between AVAI and CHF prevalence was assessed using cross-sectional data from the 2013-2018 National Health and Nutrition Examination Survey (NHANES). Logistic regression was used to assess the association between AVAI and CHF prevalence, with sequential adjustment for covariates. Subgroup analyses stratified by demographic variables and lifestyle factors were done to examine the robustness of the results. Lastly, the discriminative ability of VAI and AVAI in distinguishing individuals with and without prevalent CHF was evaluated using receiver operating characteristic (ROC) curve analysis.ResultsA total of 6,695 participants were included in the analysis, comprising 6,470 without CHF and 225 with CHF. Logistic regression revealed a significant positive association between AVAI and CHF prevalence (OR = 1.75, 95% CI: 1.62-2.89), which remained robust after adjusting for confounders (adjusted OR = 1.57, 95% CI: 1.31-1.87). In subgroup studies, AVAI was consistently associated with the prevalence of CHF. ROC analysis indicated that AVAI demonstrated superior discriminative performance compared with VAI in distinguishing individuals with and without prevalent CHF.ConclusionsThis cross-sectional study identified a significant association between AVAI and prevalent CHF. AVAI may represent a clinically relevant marker associated with the prevalence of CHF and may help identify populations with a higher likelihood of prevalent CHF for further prospective investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.